시간 외 거래: 2.12

웨어울프 테라 (HOWL)

Werewolf Therapeutics Inc 주식(HOWL)의 최신 뉴스

웨어울프 테라 (HOWL)

Werewolf Therapeutics Inc 주식(HOWL)의 최신 뉴스

Werewolf Therapeutics' SWOT analysis: innovative platform drives stock potential - Investing.com India

Rubric Capital Management LP Has $3.26 Million Stock Holdings in Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - MarketBeat

Werewolf Therapeutics (NASDAQ:HOWL) Trading Down 3.6% - MarketBeat

Werewolf Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire

Werewolf Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan

Werewolf Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - Yahoo Finance

Are Smart Investors Making the Right Decision? Werewolf Therapeutics Inc (HOWL) - SETE News

Market Recap Check: Werewolf Therapeutics Inc (HOWL)’s Negative Finish at 2.16, Up/Down -2.70 - The Dwinnex

What is the investor’s view on Werewolf Therapeutics Inc (HOWL)? - US Post News

Analysts Offer Predictions for Werewolf Therapeutics, Inc.'s Q1 2025 Earnings (NASDAQ:HOWL) - MarketBeat

Analysts Issue Forecasts for Werewolf Therapeutics, Inc.'s FY2024 Earnings (NASDAQ:HOWL) - MarketBeat

Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Forecasted to Post Q3 2024 Earnings of ($0.45) Per Share - MarketBeat

Brokers Issue Forecasts for Werewolf Therapeutics, Inc.’s Q3 2024 Earnings (NASDAQ:HOWL) - Defense World

Vanguard Group Inc. Boosts Position in Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World

Werewolf Therapeutics, Inc. (HOWL) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance

Werewolf Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

Werewolf Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update - Yahoo Finance

1,688,054 Shares in Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Bought by Janus Henderson Group PLC - MarketBeat

Is Werewolf Therapeutics (NASDAQ:HOWL) Using Debt Sensibly? - Simply Wall St

Short Interest in Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Rises By 55.1% - Defense World

Hamilton Thorne Ltd. (OTCMKTS:HTLZF) Short Interest Update - Defense World

Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Short Interest Up 55.1% in July - MarketBeat

Acadian Asset Management LLC Boosts Position in Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World

Werewolf Therapeutics Inc (HOWL) Stock: A Year of Market Fluctuations - The InvestChronicle

WEREWOLF THERAPEUTICS, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) - Marketscreener.com

RSI Oversold: 2 Stocks (HOWL, WKHS) Potentially Signaling a Contrarian Buy - Nasdaq

CFRA maintains sell on Rivian, price target at $8 By Investing.com - Investing.com India

H.C. Wainwright: Werewolf Therapeutics stock weakness 'misplaced'; reiterates buy - Investing.com

Werewolf Therapeutics (NASDAQ:HOWL) Receives Buy Rating from HC Wainwright - MarketBeat

H.C. Wainwright: Werewolf Therapeutics stock weakness 'misplaced'; reiterates buy By Investing.com - Investing.com UK

Werewolf Therapeutics (NASDAQ:HOWL) Rating Reiterated by HC Wainwright - Defense World

Werewolf Therapeutics: Continuing To Advance And Show More Promise In Phase 1 (HOWL) - Seeking Alpha

Financial Fitness Check: Examining Werewolf Therapeutics Inc (HOWL)'s Key Ratios – DWinneX - The Dwinnex

Werewolf Therapeutics Inc (HOWL) can make a big difference with a little luck – Sete News - SETE News

A stock that deserves closer examination: Werewolf Therapeutics Inc (HOWL) – US Post News - US Post News

Werewolf Therapeutics (NASDAQ:HOWL) Receives Buy Rating from HC Wainwright - Defense World

Werewolf Therapeutics (NASDAQ:HOWL) Receives “Market Outperform” Rating from JMP Securities - Defense World

Werewolf Therapeutics shares hold Buy rating By Investing.com - Investing.com Australia

Werewolf Therapeutics' (HOWL) Market Outperform Rating Reiterated at JMP Securities - MarketBeat

Flutter Entertainment announces total voting rights By Investing.com - Investing.com

Citi starts United Rentals shares coverage with buy rating, cites solid outlook By Investing.com - Investing.com South Africa

Werewolf Therapeutics shares hold Buy rating By Investing.com - Investing.com UK

Where Werewolf Therapeutics Stands With Analysts - Benzinga

Werewolf Therapeutics stock target held by BofA on early data - Investing.com

Werewolf Therapeutics Inc's Market Journey: Closing Weak at 2.34, Down -10.34 – DWinneX - The Dwinnex

Werewolf Therapeutics Reports Promising WTX-330 Trial Outcomes - TipRanks

Werewolf Therapeutics Highlights Initial Safety and Efficacy Data from its Ongoing Phase 1 Clinical Trial Evaluating ... - GlobeNewswire

Werewolf Therapeutics Highlights Initial Safety and Efficacy Data from its Ongoing Phase 1 Clinical Trial Evaluating WTX-330 in Patients with Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphoma - ForexTV.com

Werewolf Therapeutics Highlights Initial Safety and Efficacy Data from its Ongoing Phase 1 Clinical Trial Evaluating WTX-330 in Patients with Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphoma - Yahoo Finance

Werewolf Therapeutics Highlights Initial Safety and Efficacy Data from its Ongoing Phase 1 Clinical Trial Evaluating WTX-330 in Patients with Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphoma - GlobeNewswire

Closing Bell Recap: Werewolf Therapeutics Inc (HOWL) Ends at 2.89, Reflecting a -7.67 Downturn – DWinneX - The Dwinnex

Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Short Interest Up 26.1% in May - MarketBeat

SmartKem Executives Receive Stock Options and Cash Bonuses By Investing.com - Investing.com

Lighthouse Investment Partners LLC Acquires Shares of 22472 Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World

GENinCode (LON:GENI) Stock Price Up 16.7% - Defense World

Merck (MRK) Keytruda Advanced Cervical Cancer Study Meets Goal - Yahoo Lifestyle Australia

Werewolf Therapeutics (NASDAQ:HOWL) Given “Buy” Rating at HC Wainwright - Defense World

JMP Securities Reaffirms Market Outperform Rating for Werewolf Therapeutics (NASDAQ:HOWL) - MarketBeat

Some Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Shareholders Look For Exit As Shares Take 34% Pounding - Simply Wall St

Werewolf Therapeutics (NASDAQ:HOWL) Receives “Outperform” Rating from Wedbush - Defense World

Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Sees Large Decline in Short Interest - MarketBeat

12 Health Care Stocks Moving In Monday's Intraday SessionConcord Medical Services (NYSE:CCM), Bio-Path - Benzinga

Werewolf Therapeutics (NASDAQ:HOWL) Given Outperform Rating at Wedbush - MarketBeat

HOWL과 유사한 종목